UK-414,495
Molecular Formula: C16H25N3O3S
Molecular Weight: 339.453
UK 414495
CAS 388630-36-2
OF
(-)-(2R)-2-[[1-[[(5-Ethyl-1,3,4-thiadiazol-2-yl)amino]carbonyl]cyclopentyl]methyl]pentanoic acid;
AND
Cyclopentanepropanoic acid, 1-[[(5-ethyl-1,3,4-thiadiazol-2-yl)amino]carbonyl]-α-propyl-, (αR)-
((R)-2-({1-[(5-ethyl-1,3,4-thiadiazol-2-yl) carbamoyl]cyclopentyl}methyl) valeric acid)
(2R)-2-[(1-{[(5-Ethyl-1,3,4-thiadiazol-2-yl)amino]carbonyl}cyclopentyl) methyl]pentanoic acid
…………………………………………………
Cas 337962-93-3 RACEMIC…………2-[[1-[[(5-Ethyl-1,3,4-thiadiazol-2-yl)amino]carbonyl]cyclopentyl]methyl]pentanoic acid
…………………………………………………………………..
ITS ENANTIOMER
(+)-(2S)-2-[[1-[[(5-Ethyl-1,3,4-thiadiazol-2-yl)amino]carbonyl]cyclopentyl]methyl]pentanoic acid……………337962-74-0
CAS SUMMARY
Cas number | 388630-36-2 337962-74-0 (enantiomer) 337962-93-3 (racemate) 388630-59-9 (sodium salt) |
UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder.[1] UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.[2][3][4]
Female sexual arousal consists of a number of physiological responses resulting from increased…
View original post 5,026 more words